Takeda and colleagues demonstrated sustained IFN-γ signaling was shown to remodel tumor cell epigenetic responsiveness in murine models of breast cancer, lymphoma, and fibrosarcoma, conferring resistance to ICB [184, 185]. Here, IFNG is linked to neoplasm.